Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options
MG Sanda, JA Cadeddu, E Kirkby, RC Chen… - The Journal of …, 2018 - auajournals.org
Purpose: This guideline is structured to provide a clinical framework stratified by cancer
severity to facilitate care decisions and guide the specifics of implementing the selected …
severity to facilitate care decisions and guide the specifics of implementing the selected …
[HTML][HTML] Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation.
BACKGROUND For people with localised prostate cancer, active treatments are effective but
have significant side effects. Minimally invasive treatments that destroy (or ablate) either the …
have significant side effects. Minimally invasive treatments that destroy (or ablate) either the …
Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part II: recommended approaches and details of specific care options
MG Sanda, JA Cadeddu, E Kirkby, RC Chen… - The Journal of …, 2018 - auajournals.org
Purpose: This guideline is structured to provide a clinical framework stratified by cancer
severity to facilitate care decisions and guide the specifics of implementing the selected …
severity to facilitate care decisions and guide the specifics of implementing the selected …
EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease
A Heidenreich, J Bellmunt, M Bolla, S Joniau, M Mason… - European urology, 2011 - Elsevier
OBJECTIVE: Our aim was to present a summary of the 2010 version of the European
Association of Urology (EAU) guidelines on the screening, diagnosis, and treatment of …
Association of Urology (EAU) guidelines on the screening, diagnosis, and treatment of …
EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013
A Heidenreich, PJ Bastian, J Bellmunt, M Bolla… - European urology, 2014 - Elsevier
Context The most recent summary of the European Association of Urology (EAU) guidelines
on prostate cancer (PCa) was published in 2011. Objective To present a summary of the …
on prostate cancer (PCa) was published in 2011. Objective To present a summary of the …
Prostate cancer, version 2.2014
JL Mohler, PW Kantoff, AJ Armstrong… - Journal of the National …, 2014 - jnccn.org
Prostate cancer has surpassed lung cancer as the most common cancer in men in the
United States. The NCCN Guidelines for Prostate Cancer provide multidisciplinary …
United States. The NCCN Guidelines for Prostate Cancer provide multidisciplinary …
Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years
BACKGROUND: Evolution of cryotherapy for prostate cancer is likely to result in
parenchyma-sparing modifications adjacent to the urethra and neurovascular bundle …
parenchyma-sparing modifications adjacent to the urethra and neurovascular bundle …
[PDF][PDF] Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry.
Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line
Database (COLD) Registry Page 1 BJUIBJU INTERNATIONAL © 2011 THE AUTHORS …
Database (COLD) Registry Page 1 BJUIBJU INTERNATIONAL © 2011 THE AUTHORS …
[HTML][HTML] Prostate cancer: current treatment and prevention strategies
F Chen, X Zhao - Iranian Red Crescent Medical Journal, 2013 - ncbi.nlm.nih.gov
Prostate cancer is one of the life threatening disorders of male. Although, over the last two
decades, a high rate of overdiagnosis, and overtreatment has lowered the incidence rate of …
decades, a high rate of overdiagnosis, and overtreatment has lowered the incidence rate of …
[HTML][HTML] A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer
RF Wolff, S Ryder, A Bossi, A Briganti, J Crook… - European journal of …, 2015 - Elsevier
Background Prostate cancer is the second most frequently diagnosed cancer and the sixth
leading cause of cancer death in males. A systematic review of randomised controlled trials …
leading cause of cancer death in males. A systematic review of randomised controlled trials …